Filter by: patients
Home > Community Treatment Reports and Side Effects > Rituximab Infusion Treatment Report
What is Rituximab Infusion?

A study of intravenous rituximab (Rituxan®, Genentech and Biogen Idec)

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
RA (Rheumatoid Arthritis) 8 2 Efficacy_none Efficacy_cant_tell
MS (Multiple Sclerosis) 6 4 Efficacy_major Efficacy_moderate Efficacy_slight
Prevent exacerbations of disease. Improve condition. 3 2 Efficacy_major Efficacy_cant_tell
Rheumatoid Arthritis 2 0
Spinal lesions 2 2 Efficacy_major
Brain lesions 2 2 Efficacy_major

See all 17 patients currently using Rituximab Infusion

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 1
Moderate
 3
Mild
 3
None
 3

Commonly reported side effects, conditions, and hospitalizations associated with Rituximab Infusion

Nausea 4
Tremor 1
Tremor in hands 1
Hair loss 1
Headaches 1
Facial swelling 1
See all 20 reported side effects ▼ See top 6 reported side effects ▲

Reported Schedules

Frequently reported dosages based on patients currently using Rituximab Infusion. See all 19 dosages ►

  8 hr every 3 months 50 mg yearly 50 mg every other week 875 mg every 3 months 750 mg monthly 3,000 mg every 3 months 700 mg weekly 800 mg weekly 875 mg weekly 2,000 mg every other week
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Using Rituximab Infusion (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 8   Course of treatment ended: 73%
Did not seem to work 1   Did not seem to work: 9%
Personal research 1   Personal research: 9%
Doctor's advice 1   Doctor's advice: 9%
Other 1   Other: 9%
Not indicated 1   Not indicated: 9%

See all 11 patients who’ve stopped using Rituximab Infusion

Reported Duration See details about how long patients take this treatment ▼

Currently Using Rituximab Infusion

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Using Rituximab Infusion

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Rituximab Infusion

Always
 9 90%
Usually
 0 0%
Sometimes
 0 0%
Never
 1 10%

Burden

Difficulty being on treatment

Burden of Rituximab Infusion

Very
 2 20%
Somewhat
 1 10%
A little
 3 30%
Not at all
 4 40%

Cost

Paid out of pocket

Cost of Rituximab Infusion

$200+
 3 38%
$100-199
 0 0%
$50-99
 2 25%
$25-49
 0 0%
< $25
 3 38%

Report created on May 24, 2012.